Through mechanistically studies, we constructed a novel regulating axis of TRIM37/ub-H2A/TGF-β1/Smad2/3 signaling in regulating RCC tumor metastases and progression (Fig. 6J). Here, SMAD2 is linked to renal cell carcinoma.